中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Viral Diseases
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Goldman Sachs Invests US$20 Million in Ascletis
2015-12-03
Dr. Jinzi Wu was Invited to Speak at 11th Annual Gates Foundation Grand Challenges Conference
2015-10-19
Ascletis Secures US$35 Million Financing
2015-09-02
Ascletis Initiates Phase II Clinical Trial of Its Interferon-Free HCV Regimen in Taiwan
2015-08-31
Ascletis as the First Chinese Company to File Clinical Applications for Interferon-Free HCV Treatment
2015-06-24
HCV RACE IN CHINA
2015-04-13
Ascletis’ triple therapy HCV drug nails phase II trial in Chinese patients
2015-03-23
浙公网安备 33010802003344号
浙ICP备11050387号-1
